The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Travel, Accommodations, Expenses - Janssen-Cilag
A randomized phase II trial comparing switch to nivolumab with TKI continuation after 12 weeks of TKI induction therapy in metastatic renal cell carcinoma patients (NIVOSWITCH).
 
Viktor Grünwald
Stock and Other Ownership Interests - AstraZeneca; Bristol-Myers Squibb; MSD
Honoraria - Ars tempi; AstraZeneca; Bayer; Bristol-Myers Squibb; Cerulean Pharma; COCS GmbH; Eisai; EUSA Pharma; Exelixis; Ipsen; Janssen-Cilag; Lilly; MedKom Akademie; Merck Serono; MSD Oncology; NewConceptOncology; Novartis; Pfizer; PharmaMar; Promedior; Roche; Update Oncology
Consulting or Advisory Role - Bristol-Myers Squibb; Cerulean Pharma; ClinSol; Ipsen; Lilly; MSD Oncology; Novartis; Pfizer
Research Funding - Bristol-Myers Squibb; Novartis (Inst)
Travel, Accommodations, Expenses - Bayer; Bristol-Myers Squibb; Ipsen; MSD Oncology; Novartis; Pfizer
 
Carsten Grüllich
Honoraria - Bristol-Myers Squibb; Eisai; Ipsen; MSD; Roche
Consulting or Advisory Role - Bristol-Myers Squibb; Eisai; Ipsen; MSD; Roche
Travel, Accommodations, Expenses - Bristol-Myers Squibb; EUSA Pharma; Ipsen; Novartis; Roche
 
Philipp Ivanyi
Honoraria - AIM Specialty Health; AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; EUSA Pharma; Ipsen; MedKom; Merck; New Concept Oncology; Novartis; Pfizer; Roche
Consulting or Advisory Role - AIM Specialty Health; AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; EUSA Pharma; Ipsen; MedKom; Merck; New Concept Oncology; Novartis; Pfizer; Roche
Travel, Accommodations, Expenses - Bayer; Bristol-Myers Squibb; Eisai; EUSA Pharma; Ipsen; Merck
 
Manfred Wirth
No Relationships to Disclose
 
Peter Staib
Honoraria - Abbvie; Amgen; Celgene; Janssen-Cilag; Pfizer; Roche
Consulting or Advisory Role - Abbvie; Amgen; Celgene; Janssen-Cilag
Speakers' Bureau - Abbvie; Amgen; Celgene
Research Funding - Abbvie; Celgene; Novartis; Roche
Travel, Accommodations, Expenses - Abbvie; Celgene; Gilead Sciences; Pfizer; Roche
 
Martin Schostak
Honoraria - AstraZeneca; Bristol-Myers Squibb; Merck Sharp & Dohme; Roche
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Merck Sharp & Dohme; Roche
Research Funding - AstraZeneca; Bristol-Myers Squibb; Merck Sharp & Dohme; Roche
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; Merck Sharp & Dohme; Roche
 
Philip Dargatz
Honoraria - Bristol-Myers Squibb
Travel, Accommodations, Expenses - Pfizer
 
Lothar Müller
No Relationships to Disclose
 
Michael Metz
Stock and Other Ownership Interests - Novartis
Honoraria - Abbvie; Amgen; Biotest; Boehringer Ingelheim; Bristol-Myers Squibb; Hexal; MSD; Novartis; Roche
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Roche
Travel, Accommodations, Expenses - Amgen; Celgene; Octapharm
 
Lothar Bergmann
Research Funding - Bristol-Myers Squibb
Travel, Accommodations, Expenses - Roche
 
Thomas Steiner
Stock and Other Ownership Interests - Fresenius
Honoraria - Amgen (Inst); Bristol-Myers Squibb (Inst); Hexal (Inst); Janssen (Inst); MSD (Inst); Pfizer (Inst); Sanofi (Inst)
Consulting or Advisory Role - Boston Scientific (Inst); Bristol-Myers Squibb (Inst)
Research Funding - Bristol-Myers Squibb (Inst)
 
Manfred Welslau
No Relationships to Disclose
 
Anja Lorch
Honoraria - Astellas Scientific and Medical Affairs Inc; Astellas Scientific and Medical Affairs Inc; Ipsen; MSD Oncology
Consulting or Advisory Role - AstraZeneca; AstraZeneca; Bristol-Myers Squibb; Bristol-Myers Squibb; Janssen Oncology; MSD Oncology; Novartis; Novartis; Roche
Travel, Accommodations, Expenses - AstraZeneca; Ipsen; Novartis
 
Mohammad-Reza RAFIYAN
Consulting or Advisory Role - Ipsen; Janssen; Sanofi
Travel, Accommodations, Expenses - Janssen
 
Eva Hellmis
No Relationships to Disclose
 
Axel Hinke
Honoraria - Roche Pharma AG
 
Johannes Meiler
Consulting or Advisory Role - Sanofi; SKH
 
Thomas Kretz
No Relationships to Disclose
 
Wolfgang C. Loidl
Consulting or Advisory Role - Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Roche Pharma AG
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Ipsen; Janssen Oncology; Roche Pharma AG
 
Anne Flörcken
Honoraria - Bayer; Pfizer
Travel, Accommodations, Expenses - Ipsen; PharmaMar